Point72 Hong Kong’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Point72 Hong Kong’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-5,528	Closed	-$39K	–	1541
2020 Q1	$39K	Buy	+5,528	New	+$69K	0.02%	409
2019 Q3	–	Sell	-1,161	Closed	-$31K	–	1515
2019 Q2	$31K	Buy	+1,161	New	+$36.4K	0.01%	712
2018 Q3	–	Sell	-61	Closed	-$2K	–	1319
2018 Q2	$2K	Buy	+61	New	+$2.33K	﹤0.01%	804

Other funds holding PTLA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

Point72 Hong Kong's PTLA Position: Q2 2020 in Review

Point72 Hong Kong sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q2 2020, closing a stake of 5,528 shares — an estimated $39K sold.

Point72 Hong Kong first reported a position in PTLA in Q2 2018 and held it in 3 quarters. The position peaked at $39K in Q1 2020. 162 funds tracked by Wall St. Rank hold PTLA as of Q2 2020.

Point72 Hong Kong reported no remaining Portola Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
Point72 Hong Kong sold 5,528 Portola Pharmaceuticals, Inc. shares in Q2 2020, an estimated $39K.
Point72 Hong Kong first reported a position in Portola Pharmaceuticals, Inc. in Q2 2018 and held it in 3 quarters.
Point72 Hong Kong's Portola Pharmaceuticals, Inc. position peaked at $39K in Q1 2020.
162 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q2 2020.

Based on Point72 Hong Kong's 13F filing for Q2 2020, filed 14 Aug 2020.